Showing posts with label Pediatric Patients. Show all posts
Showing posts with label Pediatric Patients. Show all posts
Monday, January 18, 2021

FDA Approves Sesquient (fosphenytoin sodium) for the Treatment of Status Epilepticus in Adult and Pediatric Patients

›
Sedor Pharmaceuticals, LLC (Sedor) announced the U.S. Food and Drug Administration (FDA) spproval of  Sesquient (fosphenytoin sodium for inj...
Thursday, January 16, 2020

FDA Approves Katerzia (amlodipine) Oral Suspension for Pediatric Patients 6 Years of Age and Older

›
In continuation of my update on amlodipine Azurity Pharmaceuticals, a specialty pharmaceutical company that makes safe, high-quali...
Thursday, October 10, 2019

FDA Approves Victoza (liraglutide) for the Treatment of Pediatric Patients 10 Years or Older with Type 2 Diabetes

›
In continuation of my update on Victoza (liraglutide) The U.S. Food and Drug Administration   approved Victoza (liraglutide) injection...
Monday, October 7, 2019

FDA Approves Fragmin (dalteparin sodium) as First Anticoagulant for Venous Thromboembolism in Pediatric Patients

›
     In continuation of my update on  Dalteparin U.S. Food and Drug Administration,  approved   Fragmin   (dalteparin sodium) ...
Wednesday, July 3, 2019

FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients

›
The U.S. Food and Drug Administration today approved Mavyret (telaprevir and pibrentasvir) tablets to treat all six genotypes of hepatit...